🚀 VC round data is live in beta, check it out!
Zotefoams Valuation Multiples
Discover revenue and EBITDA valuation multiples for Zotefoams and similar public comparables like Advanced Innergy Holdings, Accsys, Aspen Aerogels, NanoXplore and more.
Zotefoams Overview
About Zotefoams
Zotefoams PLC is engaged in the manufacturing of polymer foam using bespoke autoclave technology to produce foams with attributes. Its block foams are sold under the AZOTE, T-FIT, ZOTEK, and other brand names. The company serves automotive, aerospace, packaging, industrial parts, marine, building and construction, military, medical, and sports and leisure industries. It has three main operating segments Polyolefin foams, High-Performance Products, and MuCell Extrusion LLC. The maximum revenue to the company is generated from the High-Performance Products.
Founded
1992
HQ
Employees
569
Website
Sectors
Financials (LTM)
EV
$306M
Zotefoams Financials
Zotefoams reported last 12-month revenue of $227M and EBITDA of $47M.
In the same LTM period, Zotefoams generated $47M in EBITDA and $25M in net income.
Revenue (LTM)
Zotefoams P&L
In the most recent fiscal year, Zotefoams reported revenue of $200M and EBITDA of $17M.
Zotefoams expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $227M | XXX | $200M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $62M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 31% | XXX | XXX | XXX |
| EBITDA | $47M | XXX | $17M | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 8% | XXX | XXX | XXX |
| EBIT Margin | 14% | XXX | 12% | XXX | XXX | XXX |
| Net Profit | $25M | XXX | ($4M) | XXX | XXX | XXX |
| Net Margin | 11% | XXX | (2%) | XXX | XXX | XXX |
| Net Debt | — | — | $33M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Zotefoams Stock Performance
Zotefoams has current market cap of $247M, and enterprise value of $306M.
Market Cap Evolution
Zotefoams' stock price is $5.06.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $306M | $247M | 0.0% | XXX | XXX | XXX | $-0.08 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialZotefoams Valuation Multiples
Zotefoams trades at 1.3x EV/Revenue multiple, and 6.5x EV/EBITDA.
EV / Revenue (LTM)
Zotefoams Financial Valuation Multiples
As of April 20, 2026, Zotefoams has market cap of $247M and EV of $306M.
Equity research analysts estimate Zotefoams' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Zotefoams has a P/E ratio of 9.8x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $247M | XXX | $247M | XXX | XXX | XXX |
| EV (current) | $306M | XXX | $306M | XXX | XXX | XXX |
| EV/Revenue | 1.3x | XXX | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | 6.5x | XXX | 18.4x | XXX | XXX | XXX |
| EV/EBIT | 9.3x | XXX | 12.5x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 4.9x | XXX | XXX | XXX |
| P/E | 9.8x | XXX | (66.4x) | XXX | XXX | XXX |
| EV/FCF | 18.7x | XXX | 19.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Zotefoams Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Zotefoams Margins & Growth Rates
Zotefoams' revenue in the last 12 month grew by 17%.
Zotefoams' revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Zotefoams' rule of 40 is 42% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Zotefoams' rule of X is 75% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Zotefoams Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 17% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 8% | XXX | XXX | XXX |
| EBITDA Growth | 16% | XXX | 166% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 42% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 75% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 6% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 13% | XXX | 13% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 19% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Zotefoams Public Comps
See public comps and valuation multiples for other Advanced Materials comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Zotefoams | XXX | XXX | XXX | XXX | XXX | XXX |
| Advanced Innergy Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Accsys | XXX | XXX | XXX | XXX | XXX | XXX |
| Aspen Aerogels | XXX | XXX | XXX | XXX | XXX | XXX |
| NanoXplore | XXX | XXX | XXX | XXX | XXX | XXX |
| Australian Strategic Materials | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Zotefoams M&A Activity
Zotefoams acquired XXX companies to date.
Last acquisition by Zotefoams was on XXXXXXXX, XXXXX. Zotefoams acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Zotefoams
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialZotefoams Investment Activity
Zotefoams invested in XXX companies to date.
Zotefoams made its latest investment on XXXXXXXX, XXXXX. Zotefoams invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Zotefoams
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Zotefoams
| When was Zotefoams founded? | Zotefoams was founded in 1992. |
| Where is Zotefoams headquartered? | Zotefoams is headquartered in United Kingdom. |
| How many employees does Zotefoams have? | As of today, Zotefoams has over 569 employees. |
| Who is the CEO of Zotefoams? | Zotefoams' CEO is Ronan Michael Cox. |
| Is Zotefoams publicly listed? | Yes, Zotefoams is a public company listed on London Stock Exchange. |
| What is the stock symbol of Zotefoams? | Zotefoams trades under ZTF ticker. |
| When did Zotefoams go public? | Zotefoams went public in 1995. |
| Who are competitors of Zotefoams? | Zotefoams main competitors are Advanced Innergy Holdings, Accsys, Aspen Aerogels, NanoXplore. |
| What is the current market cap of Zotefoams? | Zotefoams' current market cap is $247M. |
| What is the current revenue of Zotefoams? | Zotefoams' last 12 months revenue is $227M. |
| What is the current revenue growth of Zotefoams? | Zotefoams revenue growth (NTM/LTM) is 17%. |
| What is the current EV/Revenue multiple of Zotefoams? | Current revenue multiple of Zotefoams is 1.3x. |
| Is Zotefoams profitable? | Yes, Zotefoams is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Zotefoams? | Zotefoams' last 12 months EBITDA is $47M. |
| What is Zotefoams' EBITDA margin? | Zotefoams' last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Zotefoams? | Current EBITDA multiple of Zotefoams is 6.5x. |
| What is the current FCF of Zotefoams? | Zotefoams' last 12 months FCF is $16M. |
| What is Zotefoams' FCF margin? | Zotefoams' last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of Zotefoams? | Current FCF multiple of Zotefoams is 18.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.